Table 4.
Participant characteristics
| Intervention | Control | |||
|---|---|---|---|---|
| Patients N=101 | Caregivers N=101 | Patients N=101 | Caregivers N=101 | |
| Age, M(SD) | 62.84 (10.34) | 57.11 (12.83) | 62.18 (12.44) | 58.19 (12.61) |
| Gender, n (%) | ||||
| Female | 42 (41.6%) | 73 (72.3%) | 41 (40.6%) | 69 (68.3%) |
| Male | 59 (58.4%) | 28 (27.7%) | 60 (59.4%) | 32 (31.7%) |
| Race, n (%) | ||||
| Black of African American | 15 (16.0%) | 17 (18.9%) | 16 (16.5%) | 16 (17.0%) |
| White | 78 (83.0%) | 72 (80.0%) | 81 (83.5%) | 77 (81.9%) |
| Other/unknown | 1 (1.1%) | 1 (1.1%) | 0 (0.0%) | 1 (1.1%) |
| Ethnicity, n (%) | ||||
| Hispanic or Latino | 2 (2.0%) | 4 (2.0%) | 1 (1.0%) | 4 (2.0%) |
| Not Hispanic or Latino | 99 (98.0%) | 198 (98.0%) | 100 (99.0%) | 198 (98.0%) |
| Relationship to patient, n (%) | ||||
| Spouse/partner | 69 (68.3%) | 77 (76.2%) | ||
| Adult child | 16 (15.8%) | 8 (7.9%) | ||
| Sibling | 6 (5.9%) | 6 (5.9%) | ||
| Other/unknown | 10 (9.9%) | 10 (9.9%) | ||
| Cancer type, n (%) | ||||
| Blood | 1 (1.0%) | 3 (3.0%) | ||
| Bone | 5 (5.0%) | 2 (2.0%) | ||
| Breast | 7 (6.9%) | 5 (5.0%) | ||
| Gastrointestinal | 32 (31.7%) | 27 (26.7%) | ||
| Lung | 15 (14.8%) | 24 (23.8%) | ||
| Prostate | 19 (18.8%) | 13 (12.9%) | ||
| Other/multiple | 22 (21.8%) | 27 (26.7%) | ||